437,438 Sacituzumab govitecan (SG) received its first FDA approval for treating metastatic TNBC patients according to the results of the ASCENT trial
GLP-1 and breastfeeding: what the research actually shows This is the question that keeps new mothers up at night, right alongside the baby
The frequency of use depends on your medical condition and should be determined by your doctor
According to one report, prescriptions for semaglutide and tirzepatide together jumped by over 510% between late 2023 and mid-2025
Clinical and preclinical research demonstrates that maintaining optimal GSH levels supports liver function, immune cell activity, mitochondrial protection, and overall cellular homeostasis [3] [9]
Hernandez AV, Usmani A, Rajamanickam A, et al